Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus
- PMID: 9401706
- DOI: 10.1016/s0166-4328(97)02305-x
Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus
Abstract
If a stimulus (e.g. light) is repeatedly preexposed without consequences, it subsequently develops a weaker association with a reinforcer (e.g. foot shock) than does a non-preexposed stimulus. This retarded conditioning to the preexposed as compared to the non-preexposed stimulus, is latent inhibition (LI). It is well documented that LI is disrupted by low doses of amphetamine and potentiated by neuroleptic drugs, and there is evidence that the action of these agents on LI can be modified by changes in the parameters of preexposure or conditioning. The present experiments tested whether the effects of DA agents on LI are influenced by the nature of the stimulus. In two experiments, LI was assessed using an off-baseline conditioned emotional response (CER) procedure in rats licking for water, consisting of three stages: preexposure, in which the stimulus (a light) to be conditioned, was repeatedly presented without being followed by reinforcement; conditioning, in which the preexposed stimulus was paired with reinforcement (a foot-shock); and test, in which LI was indexed by animals' degree of suppression of licking during stimulus presentation. In both experiments, different groups of animals were preexposed and conditioned with four different preexposed visual stimuli: three steady side-lights, three flashing side-lights, one flashing side-light, and a flashing houselight. Experiment 1 used 40 stimulus preexposures and tested the effects of 1 mg/kg D-amphetamine, whereas experiment 2 used 10 preexposures and tested the effects of 0.1 mg/kg haloperidol. The results showed that of the four stimuli used, both drugs were effective with only one and the same stimulus, namely, flashing houselight. This demonstrates that the disruptive effect of amphetamine and the potentiating effect of haloperidol on LI, are modifiable by manipulating the nature of the preexposed stimulus.
Similar articles
-
Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated.Pharmacol Biochem Behav. 1997 Apr;56(4):817-26. doi: 10.1016/s0091-3057(96)00417-0. Pharmacol Biochem Behav. 1997. PMID: 9130310
-
Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.Neuropsychopharmacology. 1997 Jan;16(1):42-50. doi: 10.1016/S0893-133X(96)00145-5. Neuropsychopharmacology. 1997. PMID: 8981387
-
Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.Behav Pharmacol. 1998 May;9(3):245-53. Behav Pharmacol. 1998. PMID: 9832938
-
Latent inhibition: the nucleus accumbens connection revisited.Behav Brain Res. 1997 Oct;88(1):27-34. doi: 10.1016/s0166-4328(97)02313-9. Behav Brain Res. 1997. PMID: 9401705 Review.
-
Latent inhibition as a measure of learned inattention: some problems and solutions.Behav Brain Res. 1997 Oct;88(1):75-83. doi: 10.1016/s0166-4328(97)02307-3. Behav Brain Res. 1997. PMID: 9401711 Review.
Cited by
-
A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition.Psychopharmacology (Berl). 2005 Jan;177(3):272-9. doi: 10.1007/s00213-004-1943-2. Epub 2004 Aug 13. Psychopharmacology (Berl). 2005. PMID: 15316712
-
Dopaminergic regulation of neuronal excitability through modulation of Ih in layer V entorhinal cortex.J Neurosci. 2006 Mar 22;26(12):3229-44. doi: 10.1523/JNEUROSCI.4333-05.2006. J Neurosci. 2006. PMID: 16554474 Free PMC article.
-
Deficits in latent inhibition induced by estradiol replacement are ameliorated by haloperidol treatment.Front Behav Neurosci. 2013 Oct 1;7:136. doi: 10.3389/fnbeh.2013.00136. eCollection 2013. Front Behav Neurosci. 2013. PMID: 24101897 Free PMC article.
-
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97. doi: 10.1007/s00213-002-1313-x. Epub 2003 Feb 25. Psychopharmacology (Berl). 2003. PMID: 12601500 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources